Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Launch Two Acquisition A | LPBB | Dec 27, 2024 | 9.94 | 0.00 |
Launch Two Acquisition Units | LPBBU | Dec 27, 2024 | 10.05 | 0.00 |
Laureate Education | LAUR | Dec 27, 2024 | 18.21 | -1.83 |
LAVA Therapeutics | LVTX | Dec 27, 2024 | 0.99 | +0.14 |
Lavoro | LVRO | Dec 27, 2024 | 4.83 | -6.31 |
Lazard A | LAZ | Dec 27, 2024 | 51.96 | -0.08 |
Lazard Global Total Return and Income Fund | LGI | Dec 27, 2024 | 16.20 | -0.64 |
Lazydays | GORV | Dec 27, 2024 | 0.84 | -5.71 |
LCI Industries | LCII | Dec 27, 2024 | 102.69 | -1.62 |
LCNB | LCNB | Dec 27, 2024 | 14.94 | -2.73 |
Lead Real Estate ADR | LRE | Dec 27, 2024 | 1.97 | +3.69 |
Leafly | LFLY | Dec 27, 2024 | 1.57 | -6.55 |
Leap Therapeutics | LPTX | Dec 27, 2024 | 2.95 | -1.01 |
Lear | LEA | Dec 27, 2024 | 95.36 | +0.38 |
LeddarTech | LDTC | Dec 27, 2024 | 1.07 | -10.08 |
Lee Enterprises | LEE | Dec 27, 2024 | 14.65 | -1.35 |
Legacy Housing | LEGH | Dec 27, 2024 | 24.80 | -1.51 |
LegalZoom.com | LZ | Dec 27, 2024 | 7.82 | -1.14 |
Legato Merger III | LEGT | Dec 27, 2024 | 10.29 | 0.00 |
Legend Biotech ADR | LEGN | Dec 27, 2024 | 32.49 | -0.88 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Dec 27, 2024 | 38.80 | -0.39 |
Leggett & Platt | LEG | Dec 27, 2024 | 9.56 | -0.73 |
Leidos | LDOS | Dec 27, 2024 | 144.49 | -0.84 |
Leishen Energy Holding Co | LSE | Dec 27, 2024 | 4.76 | 0.00 |
LeMaitre Vascular | LMAT | Dec 27, 2024 | 92.84 | -1.28 |
Lemonade | LMND | Dec 27, 2024 | 39.40 | -10.78 |
LendingClub | LC | Dec 27, 2024 | 16.71 | -3.24 |
LendingTree | TREE | Dec 27, 2024 | 39.25 | -2.58 |
Lendway | LDWY | Dec 27, 2024 | 4.84 | -3.11 |
Lennar A | LEN | Dec 27, 2024 | 137.19 | -1.05 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.